By which route is CARVYKTI (ciltacabtagene autoleucel) administered?

Sources for this answer

• CARVYKTI 3.2 × 10^6 – 1 × 10^8 cells dispersion for infusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.2 Posology and method of administration · Version 6Document updated 18 June 2026

Sources checked 8 November 2026